Identification and functional characterization of extracellular vesicles involved in the pathophysiology of Alzheimer’s Disease: focus on miRNAs as inflammatory modulators and biomarkers.

PRIN 2022 Massenzio

Abstract

Alzheimer's disease (AD), the most common form of dementia, is marked by amyloid plaque (Aβ) accumulation, tau hyperphosphorylation, neuroinflammation, and neuronal degeneration. Despite significant efforts, effective treatment remains lacking. Disrupted communication between neurons and glia plays a key role in AD onset, with microglia-mediated neuroinflammation exacerbating neuronal damage. Extracellular vesicles (EVs) are involved in spreading neuroinflammation and toxic protein aggregates. EVs from neural stem cells (NSC-EVs) show promise in modulating neuroinflammation and enhancing neurogenesis in AD models. This study aims to examine adult neurogenesis and EV characteristics in the 5XFAD model, focusing on miRNA profiles and their potential as therapeutic targets for AD, which may lead to innovative treatments.

Dettagli del progetto

Responsabile scientifico: Francesca Massenzio

Strutture Unibo coinvolte:
Dipartimento di Farmacia e Biotecnologie

Coordinatore:
Università degli studi di Modena e Reggio Emilia - UNIMORE(Italy)

Contributo totale Unibo: Euro (EUR) 93.894,00
Durata del progetto in mesi: 24
Data di inizio 18/10/2023
Data di fine: 28/02/2026

Loghi degli enti finanziatori